Invesaro

Stocks Health care KMDA

NASDAQ · Health care

Kamada Ltd (KMDA)

Kamada Ltd reported revenue of $180.5M in fiscal 2025, up 12.1% from a year earlier. Net income was $20.2M, a net margin of 11.2%. At December 31, 2025 it held $75.5M in cash. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on March 11, 2026.

Free, no password. An email when KMDA files with the SEC.

Price
$7.71
+6.64% on the day · November 9, 2026
52-week range $6.60 to $9.35
Market cap
$444.8M
Revenue (FY2025)
$180.5M
+12.1% year on year
Net margin
11.2%

Key facts about Kamada Ltd

Net worth
Kamada Ltd has a market value (market cap) of $444.8M at the latest share price, and shareholders' equity of $269.1M on its balance sheet at December 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2025 revenue was $180.5M (+12.1% year on year), with net income of $20.2M.
Cash flow
In fiscal 2025 operations brought in $25.5M of cash.
Latest report
The latest periodic report (annual report (foreign issuer), 20-F) was filed with the SEC on March 11, 2026 and covers the period to December 31, 2025. Open on SEC EDGAR

What Kamada Ltd does

Kamada Ltd is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker KMDA.

Revenue and profit by year

Revenue
FY18: $114.5M $114.5M FY18FY19: $127.2M $127.2M FY19FY20: $133.2M $133.2M FY20FY21: $103.6M $103.6M FY21FY22: $129.3M $129.3M FY22FY23: $142.5M $142.5M FY23FY24: $161M $161M FY24FY25: $180.5M $180.5M FY25
Net income
FY18: $22.3M $22.3M FY18FY19: $22.3M $22.3M FY19FY20: $17.1M $17.1M FY20FY21: -$2.2M -$2.2M FY21FY22: -$2.3M -$2.3M FY22FY23: $8.3M $8.3M FY23FY24: $14.5M $14.5M FY24FY25: $20.2M $20.2M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$180.5M$26.2M$20.2M$0.35n/a
2024$161M$20.1M$14.5M$0.25n/a
2023$142.5M$10.1M$8.3M$0.15n/a
2022$129.3M$4.5M-$2.3M-$0.05n/a
2021$103.6M-$696K-$2.2M-$0.05n/a
2020$133.2M$19.2M$17.1M$0.38n/a

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Where KMDA ranks in Health care

Revenue$180.5M
#282 of 751 in Health care · Top 37%
Revenue growth+12.1%
#256 of 532 in Health care · Top 48%
Net margin11.2%
#103 of 544 in Health care · Top 19%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Dividends

It paid out $11.5M in cash dividends, 57% of its net income.

Fiscal yearPer sharePaid outOf profit
2025n/a$11.5M57%

Per share as declared (or paid, where only that is reported), adjusted for stock splits the company itself restated. Yield is the latest fiscal year's dividend over the current price.

Latest SEC filings

What Kamada Ltd has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. November 9, 2026
  2. November 2, 2026
  3. October 6, 2026
  4. October 5, 2026
  5. September 17, 2026
  6. September 10, 2026
  7. September 9, 2026
  8. September 3, 2026
  9. August 20, 2026
  10. August 17, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 29, 2026. Insider transactions on SEC

Insider trades

What the people running Kamada Ltd did with its shares, from the Form 4 filings they must send the SEC within two business days.

Insiders sold $1.7M worth of shares in the last 90 days and bought none on the open market.

Bought (open market)
$0
last 90 days
Sold
$1.7M
last 90 days
Net sold
200,000
$1.7M
DateInsiderWhatSharesPriceValueFiling
September 14, 2026 Tsur DavidDirector Sold 22,827 $8.18 $186.7K Form 4
September 14, 2026 Livneh NirVP, General Counsel Exercised options 10,000 $5.37 $53.7K Form 4
September 14, 2026 Livneh NirVP, General Counsel Shares withheld for tax 3,459 $8.35 $28.9K Form 4
September 14, 2026 Brenner YaelVP Quality Exercised options 5,000 $5.93 $29.7K Form 4
September 14, 2026 Brenner YaelVP Quality Shares withheld for tax 1,371 $8.36 $11.5K Form 4
September 14, 2026 Brenner YaelVP Quality Exercised options 5,000 $5.93 $29.7K Form 4
September 14, 2026 Brenner YaelVP Quality Shares withheld for tax 1,371 $8.36 $11.5K Form 4
September 14, 2026 Brenner YaelVP Quality Exercised options 5,000 $5.93 $29.7K Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns KMDA

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Leon Recanati13G, passive with 2 related filers 6.07% 3,489,439 March 5, 2025
Recanati Leon13G, passive with 2 related filers 6% 3,481,937 March 16, 2026

Latest filings below 5%: Phoenix Financial Ltd. 4.6% (August 20, 2026).

Largest institutional holders

Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 51 managers reported a position.

HolderSharesValueChange on quarter
Phoenix Financial Ltd.1,654,952$12.1M0
Renaissance Technologies LLC742,418$5.4M-20,530
Wells Fargo & Company592,064$4.3M-5,172
Dimensional Fund Advisors LP301,680$2.2Mnew
ARK Investment Management LLC263,304$1.9M-6,253
Huntleigh Advisors, Inc.162,644$1.2M+7,188
Two Sigma Investments, LP151,100$1.1M-43,145
Renaissance Group LLC124,896$916.7K-1,005
Marshall Wace, Llp75,182$551.8K-74,811
Man Group plc61,889$454.3K+7,131
Goldman Sachs Group Inc59,046$433.4K-13,909
Envestnet Asset Management Inc54,669$401.3K-111,467
Prudential Financial Inc16,227$354.7Knew
BlackRock, Inc.45,374$333K+847
Stifel Financial Corp38,399$281.8Knew
Geode Capital Management, LLC37,503$275.3K0
Aristides Capital LLC36,031$264.5K+1,540
Quadrature Capital Ltd34,250$251.4K+4,056
XTX Topco Ltd31,350$230.1Knew
Millennium Management LLC29,206$214.4K-17,728

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

2 insiders reported holding 414,195 shares in total, about $3.2M at the last price.

HolderSharesAs of
Tsur DavidDirector 407,929 September 14, 2026
Brenner YaelVP Quality 6,266 September 14, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about KMDA

What does Kamada Ltd do?

Kamada Ltd is a company in the Health care sector, listed on NASDAQ as KMDA. Its shares trade on NASDAQ under the ticker KMDA.

What is Kamada Ltd's net worth?

Kamada Ltd has a market value (market cap) of $444.8M at the latest share price, and shareholders' equity of $269.1M on its balance sheet at December 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Kamada Ltd profitable?

Yes. In fiscal 2025 it reported net income of $20.2M on revenue of $180.5M, a net margin of 11.2%.

How much revenue does Kamada Ltd make?

In fiscal 2025 Kamada Ltd reported revenue of $180.5M. That is 12.1% more than a year earlier.

When did Kamada Ltd last report?

Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on March 11, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the foreign issuer update from November 9, 2026.

Similar companies

Compare KMDA with

Compare KMDA with any company

Follow KMDA

Get an email when Kamada Ltd files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when KMDA files with the SEC.

Where the numbers come from

Financial figures are the values Kamada Ltd tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.